Brain Tumor Surgery in India for Canadian Patients

Author:- Dr. Dheeraj Bojwani Date Created:- 11-08-2026

Read This Before Anything Else in This Document

Key Takeaways

• “Brain tumour” describes a wide range of conditions, and the PDF emphasizes that many have favourable treatment outcomes when the diagnosis is matched with the right team and technology. Meningiomas are usually benign and are frequently treated successfully with surgery alone, while pituitary adenomas, acoustic neuromas and gliomas require different approaches.
• The guide highlights several technologies that can meaningfully influence surgery, including fluorescence-guided resection, awake craniotomy with intraoperative mapping and neuronavigation. For gliomas, molecular testing such as IDH mutation status, MGMT methylation and 1p/19q co-deletion is presented as central to modern diagnosis and treatment planning.
• The chart on page 3 illustrates the relationship between extent of resection and outcomes in high-grade glioma, with illustrative median-survival figures increasing from 12 months for subtotal resection to 15.5 months for near-total and 20.7 months for gross-total resection. The PDF also stresses that maximum removal is not always appropriate when critical brain functions are at risk.
• Canadian patients should therefore focus on whether the surgeon has specific experience with their tumour type and whether the required technology will actually be used in their operation, rather than choosing a hospital simply because it offers advanced equipment.
• The guide recommends a genuine multidisciplinary team involving neurosurgery, radiation oncology and neuroradiology, together with complete molecular pathology where relevant. It also recommends independently verifiable JCI or NABH accreditation.
• The page 4 cost chart gives indicative India figures of approximately C$13,800 for meningioma resection, C$11,200 for pituitary tumour endoscopic removal, C$15,600 for acoustic neuroma removal and C$16,500 for glioma resection with mapping, compared with substantially higher US private-care costs.
• The PDF recommends obtaining six important items in writing before travelling, including the planned technology, awake mapping where relevant, the surgeon's tumour-specific annual volume, pathology testing, an itemised price and an agreed Canadian follow-up plan.

Quick Facts

Treatment

Brain Tumor Surgery

Country

India

Patients

Canadian Patients

Specialty

Neurosurgery / Neuro-Oncology

Common Tumours Discussed

Meningioma, Pituitary Adenoma, Acoustic Neuroma, Metastatic Tumours and Glioma

Meningioma

Usually Benign and Frequently Treated With Surgery Alone

Pituitary Adenoma

May Be Treated With Surgery or Medication Depending on the Case

Acoustic Neuroma

Slow-Growing; Hearing and Facial Function Preservation May Be Considered

Glioma

Behaviour Varies; Molecular Testing Helps Guide Treatment Planning

Advanced Techniques

Fluorescence-Guided Resection, Awake Craniotomy, Intraoperative Mapping and Neuronavigation

Molecular Testing

IDH, MGMT and 1p/19q Testing for Relevant Gliomas

Travel

Changeable Ticket Recommended

Fit-to-Fly

Documented Assessment Before Returning to Canada

Follow-Up

Canadian Neuro-Oncology Team

In Brief

Brain tumour surgery should be planned around the specific tumour type, location and functional risks, rather than around the label “brain tumour” alone. A well-equipped neuro-oncology team may use fluorescence guidance, awake mapping, neuronavigation and molecular pathology where appropriate. Canadian patients should confirm the surgeon's specific tumour experience, the technology planned for their operation, complete pathology, an itemised treatment cost and a documented follow-up arrangement with their Canadian neuro-oncology team.

"Brain tumour" describes a wide range of conditions, most with good outcomes

Canadian neurosurgeons are excellent, and in 24 years of guiding international patients into Indian hospitals I have never suggested otherwise. The first thing worth understanding, because the word "tumour" alone can sound frightening, is how wide a range of conditions this actually covers — and how many of them carry genuinely favourable outlooks.

Meningiomas, among the most common brain tumours found, are usually benign and are frequently cured with surgery alone. Pituitary adenomas are often highly treatable, sometimes with surgery, sometimes with medication alone. Acoustic neuromas grow slowly, and modern surgical technique can often preserve hearing and facial function. Even glioma, the category that includes the more serious high-grade tumours, ranges widely in behaviour, and modern surgery combined with molecular testing now allows treatment to be planned with real precision for each individual case.

What a modern neuro-oncology team brings to your specific tumour

Whatever your diagnosis, the tools available to a well-equipped surgical team meaningfully shape the result.

Fluorescence-guided resection, using a compound that causes high-grade tumour tissue to glow under specific light, helps a surgeon see margins that are otherwise invisible. Awake craniotomy with intraoperative mapping allows a team to identify and protect speech, motor and other critical functions directly during surgery, for tumours near these sensitive areas. Neuronavigation tracks instruments against pre-operative imaging in real time. And since 2021, molecular testing — IDH mutation status, MGMT methylation, and 1p/19q co-deletion for gliomas specifically — has become central to accurate diagnosis and treatment planning under current international classification standards, not simply a prognostic add-on.

Ask your team directly which of these apply to your specific tumour, and how they will be used in your case. A well-resourced centre combining the right tools with real experience in your tumour type is the combination genuinely worth seeking out, wherever that centre is.

Why a complete, well-planned resection matters

For tumours where surgical removal is the primary goal, how completely and safely that removal is achieved genuinely affects the outcome.

This relationship, seen clearly in high-grade glioma research, illustrates a principle that applies more broadly: surgical technique and planning matter. It is also worth saying plainly that a more aggressive resection is not always the right goal — for tumours deeply embedded near critical structures, a genuinely experienced team will sometimes recommend a more measured approach specifically to preserve function, and that judgement matters as much as the technology itself.

What the money actually looks like

Complex brain tumour surgery is not something Canada's small private surgical sector offers; it requires neuro-ICU capability, intraoperative imaging and a dedicated neuro-oncology team that exists only within larger academic centres. For a patient exploring options beyond the team currently proposed, the realistic paid alternative is the United States rather than a domestic private clinic.

American brain tumour surgery, priced for an insurance-backed domestic market, commonly runs into six figures. India's major neuro-oncology centres routinely combine fluorescence guidance, neuronavigation and awake mapping as standard practice, with full molecular pathology performed as a matter of course, at a fraction of the American price — and this holds true across tumour types, not just the more complex ones. In 24 years of guiding patients through this decision, the single most useful question a patient can ask is whether the specific tools relevant to their tumour type will actually be used in their operation.

What you are actually getting for it

The right technology matched to your specific tumour, whether that means fluorescence guidance for glioma, endoscopic technique for pituitary tumours, or hearing-preservation approaches for acoustic neuroma.

A genuine multidisciplinary team, including neurosurgery, radiation oncology and neuroradiology together, rather than a single surgeon's opinion.

Complete molecular pathology where relevant, as a routine part of diagnosis rather than an afterthought.

Accreditation you can verify independently. JCI is the international arm of the body accrediting hospitals across the United States; NABH is India's national equivalent, recognised by the same global standards authority.

A discharge record built for your Canadian neuro-oncology team to use, including operative findings, full pathology and a specific follow-up plan.

Six Things to Have in Writing Before You FLY

1. Confirmation of which specific tools will be used for your tumour type, and why.

2. Whether awake craniotomy and intraoperative mapping are planned, if your tumour is near speech or motor areas.

3. The surgeon's own annual volume in your specific tumour type, not general neurosurgery.

4. Confirmation of full molecular or pathological testing relevant to your diagnosis.

5. An itemised, all-inclusive price, naming ICU days assumed and the cost of exceeding them.

6. Your Canadian follow-up, already agreed: a named neuro-oncologist and a surveillance imaging schedule.

Straight answers

A closing word

Brain tumour treatment covers a genuinely wide range of conditions, and for most of them, modern surgery offers a confidently good outcome. The task is matching your specific diagnosis to a team with real, matching experience and the right technology for your tumour type — and then finding that the cost comparison makes an already sound decision an easy one. If you would like a second opinion on your imaging or pathology, send it to me and I will look at it properly.

Sources

• 🌐 Louis et al., "The 2021 WHO Classification of Tumors of the Central Nervous System", Neuro-Oncology — academic.oup.com
• 🌐 Medexus Pharmaceuticals, "Health Canada Approval of Gleolan (5-ALA)" — globenewswire.com
• 🌐 Brain Tumour Foundation of Canada — braintumour.ca
• 🌐 High Commission of India, e-Visa categories and eligibility — indianvisaonline.gov.in/evisa

Frequently Asked Questions

Are all brain tumours equally serious?

No. The PDF emphasizes that brain tumours cover a wide range of conditions. Many meningiomas are benign, pituitary adenomas can often be treated effectively, and acoustic neuromas are generally slow-growing. Gliomas vary considerably in behaviour.

What advanced technologies may be used during brain tumor surgery?

Depending on the tumour, a centre may use fluorescence-guided resection, awake craniotomy with intraoperative mapping and neuronavigation. The appropriate technology depends on the tumour's location and characteristics.

When is awake craniotomy and mapping important?

It may be considered when a tumour is located near important speech, motor or other functional areas. Intraoperative mapping helps the surgical team identify and protect these functions during the operation.

Why is molecular testing important for gliomas?

The guide identifies molecular testing such as IDH mutation status, MGMT methylation and 1p/19q co-deletion as important components of modern glioma diagnosis and treatment planning.

Does removing more of a brain tumour always mean a better result?

Not necessarily. Although greater safe resection can support better outcomes in some high-grade gliomas, the guide stresses that aggressive removal is not always appropriate when a tumour is close to critical brain structures. Preserving neurological function is also important.

How much does brain tumor surgery cost in India for Canadian patients?

The PDF gives indicative figures ranging from approximately C$11,200 for pituitary tumour endoscopic removal to C$16,500 for glioma resection with mapping, with other procedures falling between these figures. Actual costs depend on the individual case.

What should Canadian patients check about the neurosurgeon?

Patients should ask about the surgeon's annual experience with their specific tumour type, rather than relying on general neurosurgical volume. They should also confirm which technologies will actually be used during their operation.

What should Canadian patients check about the hospital?

The guide recommends a multidisciplinary team involving neurosurgery, radiation oncology and neuroradiology, complete molecular pathology where relevant and independently verifiable JCI or NABH accreditation.

How long should Canadian patients plan to stay in India?

The guide recommends planning for approximately two to four weeks, depending on the tumour type and complexity, with a changeable ticket and a documented fit-to-fly assessment before returning home.

Who manages follow-up after returning to Canada?

The Canadian neuro-oncology team should manage follow-up, provided it receives the operative note, complete pathology and a specific surveillance plan before the patient leaves India.

Page Summary

This guide explains brain tumor surgery options in India for Canadian patients and emphasizes that brain tumors represent a wide range of conditions with different treatment approaches. It covers modern techniques such as fluorescence-guided surgery, awake mapping, neuronavigation and molecular pathology. Patients are advised to choose a team with tumour-specific experience, multidisciplinary support and appropriate technology. The guide also provides indicative treatment costs, a pre-travel checklist and follow-up recommendations with the Canadian neuro-oncology team.

Citation Block

Topic	Information
Topic	Brain Tumor Surgery in India for Canadian Patients
Treatment	Brain Tumor Surgery
Country	India
Intended Audience	Canadian Patients
Specialty	Neurosurgery / Neuro-Oncology
Tumours Discussed	Meningioma, Pituitary Adenoma, Acoustic Neuroma, Metastatic Tumours and Glioma
Advanced Techniques	Fluorescence Guidance, Awake Mapping and Neuronavigation
Molecular Testing	IDH, MGMT and 1p/19q for Relevant Gliomas
Team Structure	Neurosurgery, Radiation Oncology and Neuroradiology
Pathology	Complete Molecular Pathology Where Relevant
Accreditation	JCI or NABH
Follow-Up	Canadian Neuro-Oncology Team
Author	Dr. Dheeraj Bojwani
Experience	24+ Years